Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Clinical trial NCT01188681 · COMPLETED
Trial details
- NCT number
- NCT01188681
- Sponsor
- Aptevo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.